US Stock MarketDetailed Quotes

CRBU Caribou Biosciences

Watchlist
  • 1.910
  • -0.030-1.55%
Close Dec 13 16:00 ET
  • 1.840
  • -0.070-3.66%
Post 19:51 ET
172.96MMarket Cap-1.15P/E (TTM)

About Caribou Biosciences Company

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.

Company Profile

SymbolCRBU
Company NameCaribou Biosciences
Listing DateJul 23, 2021
Issue Price16.00
Founded2011
CEODr. Rachel Haurwitz, PhD
MarketNASDAQ
Employees158
Fiscal Year Ends12-31
Address2929 7th Street,Suite 105
CityBerkeley
ProvinceCalifornia
CountryUnited States of America
Zip Code94710
Phone1-510-982-6030
Websitehttp://www.cariboubio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Rachel Haurwitz, PhD
  • President, Chief Executive Officer and Director
  • 3.12M
  • Barbara G. McClung, J.D.
  • Chief Legal Officer and Corporate Secretary
  • 1.22M
  • Dr. Steven B. Kanner, PhD
  • Chief Scientific Officer
  • 1.22M
  • Ruhi Ahmad Khan
  • Chief Business Officer
  • --
  • Tim Kelly
  • Chief Technology Officer
  • --
  • Ryan Fischesser
  • Principal Accounting Officer, Vice President, Finance and Controller
  • --
  • Andrew L. Guggenhime
  • Chairman of the Board
  • 202.74K
  • Dr. Natalie Sacks
  • Independent Director
  • 136.99K
  • Dr. Nancy C. Whiting, Pharm.D.
  • Independent Director
  • 140.62K
  • Ran Zheng
  • Independent Director
  • 157.20K
  • Dr. Dara Richardson-Heron
  • Independent Director
  • 141.93K
  • David L. Johnson, C.P.A.
  • Independent Director
  • 143.85K
  • Dr. Scott Braunstein, M.D.
  • Independent Director
  • 155.86K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List

Investment Theme Gene Editing
Gene Editing
Intraday-0.48%